Associated Banc Corp Sells 10,707 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Associated Banc Corp lowered its stake in Avanos Medical, Inc. (NYSE:AVNS) by 45.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,718 shares of the company’s stock after selling 10,707 shares during the quarter. Associated Banc Corp’s holdings in Avanos Medical were worth $306,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. State Board of Administration of Florida Retirement System lifted its position in Avanos Medical by 8.6% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 19,053 shares of the company’s stock worth $379,000 after buying an additional 1,516 shares in the last quarter. Tidal Investments LLC acquired a new position in Avanos Medical during the first quarter valued at approximately $439,000. Boston Partners bought a new position in Avanos Medical in the first quarter valued at approximately $571,000. Azzad Asset Management Inc. ADV raised its stake in shares of Avanos Medical by 8.5% during the 2nd quarter. Azzad Asset Management Inc. ADV now owns 28,521 shares of the company’s stock worth $568,000 after purchasing an additional 2,223 shares in the last quarter. Finally, Natixis Advisors LLC boosted its holdings in shares of Avanos Medical by 19.5% in the 2nd quarter. Natixis Advisors LLC now owns 18,878 shares of the company’s stock valued at $376,000 after buying an additional 3,077 shares during the last quarter. 95.17% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Trading Up 4.1 %

Shares of NYSE:AVNS opened at $19.37 on Tuesday. Avanos Medical, Inc. has a 52-week low of $17.39 and a 52-week high of $25.36. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The company has a market capitalization of $890.25 million, a P/E ratio of 56.97 and a beta of 0.92. The company has a 50-day simple moving average of $21.73 and a 200 day simple moving average of $21.56.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.